Jeff Yass’s CalciMedica CALC Stock Holding History

Jeff Yass’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-936	Closed	-$16K	–	12949
2022 Q1	$16K	Sell	936 -4,735	-83%	-$90.2K	﹤0.01%	12678
2021 Q4	$145K	Sell	5,671 -3,179	-36%	-$123K	﹤0.01%	11825
2021 Q3	$411K	Sell	8,850 -5,800	-40%	-$326K	﹤0.01%	9862
2021 Q2	$1.11M	Buy	+14,650	New	+$961K	﹤0.01%	7465

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's CALC Position: Q2 2026 in Review

Jeff Yass increased its CalciMedica (CALC) stake by 43% in Q2 2026, buying an estimated $9.39K and bringing the position to 43,968 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12862.

Jeff Yass first reported a position in CALC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.46M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Jeff Yass held 43,968 shares of CalciMedica worth $45.3K as of Q2 2026.
Jeff Yass bought 13,252 CalciMedica shares in Q2 2026, an estimated $9.39K.
CalciMedica made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12862 holding.
Jeff Yass first reported a position in CalciMedica in Q2 2021 and has held it in 7 quarters since.
Jeff Yass's CalciMedica position peaked at $1.46M in Q2 2021.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.